Targeting The NPL4 Adaptor Of P97/VCP Segregase By Disulfiram As An Emerging Cancer Vulnerability Evokes Replication Stress And DNA Damage While Silencing The ATR Pathway
Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway
Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway.
Cells.
2020,
9(2),
pii: E469,
ISSN: 2073-4409,
PMID: 32085572,
PDF.